Posts tagged with Pfizer

How healthcare companies are getting creative to acquire data

Data is the black gold of the 21st century. This is perhaps no truer than in the healthcare industry, where data has the potential to help address some of the biggest challenges individuals face.

As in just about every industry, the companies that need data the most aren't always the ones that collect it. In some cases, valuable data is generated and owned by third parties; in others, companies need tools and technologies offered by third parties to collect data that they have the potential to generate.

0 comments

Pfizer lures consumers to text with Viagra discounts

Taking a page from the consumer marketing playbook, pharma giant Pfizer has launched a new televison ad campaign that encourages viewers to sign up to receive text messages from the company in exchange for a discount of 50% on a year-long supply of the prescription drug Viagra.

0 comments

GSK launches digital campaign to drive meningitis vaccinations

With television ads apparently losing their sway, pharma marketers are increasingly turning to social media, despite the fact that they have numerous digital shortcomings.

A new campaign launched by GlaxoSmithKline (GSK) demonstrates why addressing those shortcomings is so important.

0 comments

Growing pains: Pfizer tackles social media

The minute we’re born, we begin to age. This was apparently the number one concern occupying respondents of a 2011 Gallup survey commissioned by pharma giant Pfizer and the finding upon which the company has based its Get Old social media campaign.

In a press release announcing the multi-year initiative that began last month, Pfizer tied it to the company’s larger mission of improving the health of all people at every stage of life.

PR platitudes aside, the initiative also marks Pfizer’s lengthening social media shadow, cast, in part, by CEO Ian Read, who has criticized the industry for being “slow to adapt” to today’s more open society. Pharma’s hesitation no doubt informs Edelman’s 2011 Trust Barometer, which found public confidence in businesses, governments, and, in a new development, NGOs slipping at a noticeable rate.

When that focus was narrowed to Pfizer alone, the results were no better: About 45 percent of respondents described the drugmaker as unethical and not credible. Not acceptable, according to Read.

0 comments